What Diseases Can Be Detected Through Genetic Testing?

Diagnosing diseases before they occur has been the dream for medicine. One such tool full of potential is genetic testing.  Did you know genetic testing can now help identify over 5000 diseases even before their symptoms occur? . From hereditary cancers to rare metabolic or neurological disorders, this powerful diagnostic tool is shaping the future of preventive medicine. In this blog, we provide a comprehensive guide on how genetic testing can detect major diseases using advanced technologies and how their results inform early intervention, family planning, and precision healthcare.

The Science Behind Genetic Testing

Before we get deeper into how genetic testing helps in detecting various diseases, let’s understand how it works! Genetic testing examines a person’s DNA to identify abnormal changes (mutations) in specific genes, chromosomes, or proteins linked to disease. At First Stem Cell and Genomics Laboratory, we utilise techniques such as polymerase chain reaction (PCR), next-generation sequencing (NGS), whole-exome sequencing (WES), and chromosomal microarray analysis to detect even subtle variations that may increase an individual’s risk of genetic disorders.

Depending on the purpose, genetic testing can be done for:

• Carrier screening (before conception)
• Prenatal testing (during pregnancy)
• Newborn screening (shortly after birth)
• Diagnostic testing (for symptomatic individuals)
• Predictive testing (in people with a family history of a disease, to estimate future disease risk)

Genetic Testing for Various Diseases

1.    Blood Disorders and Hemoglobinopathies

Thalassemia and sickle cell disease are among the most common blood disorders that are detected through genetic testing.

• Thalassemia

Thalassemia is of two types – alpha and beta – and it occurs when faulty genes reduce haemoglobin production, leading to chronic anaemia. Genetic testing for thalassemia is recommended as part of premarital and preconception screening, especially in people of Mediterranean, Middle Eastern, and South Asian ethnicities, where carrier frequency is high.

• Sickle cell disease

Sickle cell disease, like thalassemia, is also an inherited blood disorder that causes red blood cells to assume a sickle shape, reducing their ability to carry sufficient oxygen. This results in episodes of severe pain, organ complications, and increased infection risk. Carrier and newborn sickle-cell screening programs help identify at-risk individuals.

Other blood disorders that may be detected using genetic testing include:

• Haemophilia A and B: These are clotting disorders that occur due to factor VIII or IX deficiency.
• Von Willebrand disease: This is a bleeding disorder caused by a defective clotting factor.
• Factor V Leiden mutation: Increases the risk of abnormal clot formation.
• G6PD deficiency: Causes red blood cells to break down under specific triggers.
• Fanconi anaemia: A rare disease leading to bone marrow failure and leukaemia risk.

2.    Hereditary Cancers

In addition to blood disorders and haemoglobinopathies, genetic testing is also helpful in diagnosing hereditary cancers by helping identify mutations that greatly elevate future cancer risks.

• BRCA 1 and BRCA2

Two such genes that are most commonly tested for include the BRCA1 and BRCA2. Mutations in these genes dramatically increased lifetime breast (45–85%) and ovarian (20–40%) cancer risk. BRCA testing helps women and families take preventive measures, such as improved screening or preventive surgery.

At the First Stem Cell and Genomics Laboratory, we offer comprehensive cancer panels that simultaneously test 50 to 180+ genes, providing a detailed risk map for the detection of hereditary diseases.

3.    Metabolic and Enzyme Disorders

Genetic testing has been useful in effectively detecting metabolic and enzyme disorders that disrupt the body’s ability to process nutrients.

Common metabolic disorders identified through genetic testing include:

• Phenylketonuria (PKU): This metabolic disorder is characterised by the body’s inability to break down phenylalanine. It can lead to brain damage if untreated.
• Cystic Fibrosis: A mutation in the CFTR gene can affect the lungs and the digestive system. Cystic fibrosis testing is now routine in carrier and newborn screening programs.
• Gaucher Disease: This condition is characterised by enzyme deficiency, which causes organ enlargement and bone problems.
• Tay-Sachs Disease: This is a fatal neurodegenerative condition seen mainly in certain ethnic populations.
• Maple Syrup Urine Disease (MSUD) and Galactosemia: Both these conditions can cause life-threatening metabolic crises if undiagnosed.

Due to the advanced genetic testing technologies available today, they are used for newborn screening to detect many of these diseases before symptoms appear. Comprehensive metabolic panels can identify over 100 enzyme and metabolic disorders.

4.    Cardiovascular Genetic Disorders

Some cardiovascular disorders have a genetic basis and can be detected early through genetic testing. Some of these include:

• Hypertrophic Cardiomyopathy (HCM): It causes abnormal thickening of the heart muscle and can result in sudden cardiac death in young athletes.
• Long QT Syndrome: It leads to irregular heart rhythms and possible sudden fainting or cardiac arrest.
• Familial Hypercholesterolemia: Causes excessively high cholesterol from birth, increasing heart disease risk.

5.    Neurological and Neuromuscular Disorders

Genetic testing for neurological diseases enables the early detection of conditions that affect the brain, spinal cord, and muscles. Some of these conditions include:

• Huntington’s Disease: This is a progressive, inherited neurodegenerative disorder that causes uncontrolled movement (chorea) and cognitive decline.
• Spinal Muscular Atrophy (SMA): This inherited condition causes progressive muscle weakness and respiratory difficulties.
• Duchenne and Becker Muscular Dystrophy: These X-linked disorders result in muscle degeneration.
• Fragile X Syndrome: The leading hereditary cause of intellectual disability.
• Charcot-Marie-Tooth Disease: Damages peripheral nerves, leading to weakness and numbness.
• Early-onset Alzheimer’s and Parkinson’s diseases can also result from inherited mutations.
• Epilepsy syndromes and ataxias are increasingly detected via whole-exome sequencing (WES).

In addition to early diagnosis and management, genetic testing for neurological disorders also aids in family planning.

6.    Chromosomal Abnormalities

Chromosomal abnormalities can be either structural defects or numerical, both of which result in developmental issues. Common chromosomal abnormalities that genetic testing can help identify prenatally include:

• Trisomies: Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13).
• Sex chromosome abnormalities: Turner’s (45, X), Klinefelter (47, XXY), Triple X, and XYY syndromes– all of which affect growth, fertility, and cognitive development.
• Microdeletion syndromes, including DiGeorge syndrome (22q11.2 deletion syndrome), Prader-Willi syndrome, Angelman syndrome, and Williams syndrome, can all cause complex physical and neurological symptoms.

Detection methods include chromosomal microarray, karyotyping, and non-invasive prenatal testing (NIPT). These tools provide insights into both chromosomal and subchromosomal variations that lead to developmental disorders.

7.    Immune, Developmental, and Other Genetic Disorders

Gene mutations can also affect the immune system and have reproductive or developmental repercussions. Immune system disorders include Severe Combined Immunodeficiency (SCID), Common Variable Immunodeficiency, and Chronic Granulomatous Disease, compromising infection resistance from infancy.

Other inherited diseases that can be detected using genetic testing include:

• Connective tissue diseases (Ehlers-Danlos and Marfan syndromes)
• Eye conditions (Retinitis Pigmentosa and Stargardt disease)
• Genetic hearing loss due to GJB2 mutations
• Polycystic kidney disease
• Skeletal dysplasias such as Achondroplasia

Genetic Testing Technologies

Modern laboratories, such as First Stem Cell and Genomics Laboratories, utilise advanced techniques to diagnose hereditary and genetic conditions with utmost precision. Some of the techniques we use include:

• Single-gene testing: These tests can identify a specific mutation in a suspected gene.
• Panel testing: We offer comprehensive panel tests that check for multiple genes related to a specific disease type, such as cancer or metabolic disorders.
• Whole Exome Sequencing (WES): Reviews all protein-coding regions (~20,000 genes).
• Whole Genome Sequencing (WGS): The most comprehensive test, covering almost the entire DNA sequence.
• Chromosomal microarray: Detects structural chromosomal variations.
• Flow cytometry: This genetic test evaluates blood and immune-related disorders.

When opting for genetic testing, always choose a lab that is GMP-certified, as this ensures high accuracy, safety, and reproducibility.

Understanding Test Results and Limitations

The results of genetic tests are usually one of the three options:

• Positive: This means the disease-causing mutation or carrier state is confirmed.
• Negative: No known mutations detected.
• Variant of Uncertain Significance (VUS): This means a mutation has been detected, but its impact is unknown.

While genetic testing has been truly transformative for modern medicine, it has its limitations:

• Not all diseases have identifiable genetic causes
• A negative result does not guarantee the absence of disease.
• Environmental and lifestyle factors often influence the expression of disease.

Interpreting genetic test results can be a challenging task. Therefore, genetic counselling plays a vital role in helping individuals understand risks, testing options, and the implications for family planning.

When is Genetic Counselling Essential?

Genetic counselling may be recommended in the following scenarios:

• To interpret complex genetic test results
• To understand disease risks
• To help make family planning decisions
• To discuss testing options

Frequently Asked Questions About Genetic Testing

1. What types of diseases can genetic testing detect?

Genetic testing can help diagnose blood disorders, cancer, metabolic disorders, neurodegenerative disorders, and immune disorders. It can also help detect chromosomal abnormalities.

2. Can genetic testing detect all diseases?

Unfortunately, not! Some diseases that are not yet genetically characterised or those with environmental triggers cannot be detected using genetic testing.

3. Can genetic testing predict future diseases?

Predictive genetic testing identifies inherited risks even before symptoms appear, improving management and prognosis.

4. What’s the difference between diagnostic and predictive testing?

Diagnostic genetic testing helps confirm a condition in individuals who are symptomatic. Predictive testing only estimates the future risk of disease.

5. What diseases are included in newborn screening?

Newborn screening diseases include PKU, cystic fibrosis, galactosemia, and congenital hypothyroidism.

6. Can genetic testing detect heart or cancer risks?

Specific genetic tests are available to help screen for hereditary cardiac conditions and cancers, such as BRCA and Lynch syndrome.

7. Does a positive result mean I will develop the disease?

Not necessarily. It indicates a higher risk, but factors such as lifestyle and environment also play a role.

Wrapping it Up: The Power and Promise of Genetic Disease Detection

Genetic testing makes it possible to identify thousands of hereditary diseases—from thalassemia, cystic fibrosis, and haemophilia to BRCA-linked cancers and Down syndrome, before symptoms arise. This enables early intervention, personalized treatment, guides preventive strategies and integrates seamlessly into precision medicine.

To learn more, schedule a consultation call with our experts at First Stem Cell and Genomics Laboratory.